Display options
Cite
Zhou X, Cui G, Tseng HH, et al. Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. Evid Based Complement Alternat Med. 2016;2016:9627258doi: 10.1155/2016/9627258.
Zhou, X., Cui, G., Tseng, H. H., Lee, S. M., Leung, G. P., Chan, S. W., Kwan, Y. W., & Hoi, M. P. (2016). Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. Evidence-based complementary and alternative medicine : eCAM, 20169627258. https://doi.org/10.1155/2016/9627258
Zhou, Xinhua, et al. "Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine." Evidence-based complementary and alternative medicine : eCAM vol. 2016 (2016): 9627258. doi: https://doi.org/10.1155/2016/9627258
Zhou X, Cui G, Tseng HH, Lee SM, Leung GP, Chan SW, Kwan YW, Hoi MP. Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. Evid Based Complement Alternat Med. 2016;2016:9627258. doi: 10.1155/2016/9627258. Epub 2016 Nov 23. PMID: 28042305; PMCID: PMC5141557.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2016;2016:9627258. doi: 10.1155/2016/9627258. Epub 2016 Nov 23.

Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine.

Evidence-based complementary and alternative medicine : eCAM

Xinhua Zhou, Guozhen Cui, Hisa Hui Ling Tseng, Simon Ming-Yuen Lee, George Pak Heng Leung, Shun Wan Chan, Yiu Wa Kwan, Maggie Pui Man Hoi

Affiliations

  1. State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau.
  2. Department of Bioengineering, Zunyi Medical University, Zhuhai Campus, Guangdong, Zhuhai, China.
  3. State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong.
  4. State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong; Department of Food and Health Sciences, Faculty of Science and Technology, Technological and Higher Education Institute of Hong Kong, Hong Kong.
  5. School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong.

PMID: 28042305 PMCID: PMC5141557 DOI: 10.1155/2016/9627258

Abstract

The prevalence of cognitive impairment and dementia caused by cerebrovascular disease is likely to increase with the global aging population. Vascular contributions to cognitive impairment and dementia (VCID) is a wide spectrum term used to include a diverse heterogeneous group of cognitive syndromes with vascular factors regardless of the cause of pathogenesis. VCID ranges from mild cognitive impairment to full-blown dementia with vascular dementia (VaD) as the most severe stage. It is further complexed by the coexistence of other forms of dementia such as Alzheimer's disease (AD). Recent researches in the functions of the neurovascular unit (NVU) suggest that dysfunction of the NVU might be the cause of primary vascular events in the brain that leads to further neurodegeneration. In this review, we have briefly summarized various forms of VCID. There is currently no standard therapy for VCID or dementia. Given the fact that Traditional Chinese Medicine (TCM) has gained popularity worldwide, we also reviewed recent scientific and clinical findings on various antidementia TCM for the treatment of VCID, including

Conflict of interest statement

The authors declare that they have no competing interests.

References

  1. J Ginseng Res. 2012 Oct;36(4):342-53 - PubMed
  2. Chin Med. 2010 Jun 21;5:22 - PubMed
  3. J Neurosci Res. 2002 Jun 1;68(5):636-45 - PubMed
  4. Evid Based Complement Alternat Med. 2014;2014:363985 - PubMed
  5. Acta Neuropathol. 2008 Nov;116(5):529-35 - PubMed
  6. J Acupunct Meridian Stud. 2013 Feb;6(1):2-11 - PubMed
  7. Evid Based Complement Alternat Med. 2014;2014:107501 - PubMed
  8. Neurosci Lett. 2013 May 24;543:121-5 - PubMed
  9. Stroke. 1998 Jan;29(1):75-81 - PubMed
  10. J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2626-34 - PubMed
  11. Nat Rev Neurosci. 2004 May;5(5):347-60 - PubMed
  12. Neuroscience. 2007 Oct 26;149(2):256-62 - PubMed
  13. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706 - PubMed
  14. Stroke. 1996 Oct;27(10):1798-803 - PubMed
  15. Evid Based Complement Alternat Med. 2015;2015:394926 - PubMed
  16. Neurochem Int. 2006 Feb;48(3):166-76 - PubMed
  17. Nat Rev Cardiol. 2015 Feb;12(2):115-22 - PubMed
  18. Behav Brain Res. 2006 Nov 1;174(1):70-7 - PubMed
  19. J Cereb Blood Flow Metab. 2012 Jul;32(7):1207-21 - PubMed
  20. Pharmacopsychiatry. 1996 Mar;29(2):47-56 - PubMed
  21. Acta Neuropathol. 2010 Sep;120(3):287-96 - PubMed
  22. PLoS One. 2014 Nov 26;9(11):e113126 - PubMed
  23. Stroke. 1998 Oct;29(10):2087-93 - PubMed
  24. Br Med Bull. 2007;83:291-305 - PubMed
  25. J Neurol Sci. 2012 Nov 15;322(1-2):2-10 - PubMed
  26. Evid Based Complement Alternat Med. 2012;2012:692621 - PubMed
  27. Pharmacopsychiatry. 2012 Mar;45(2):41-6 - PubMed
  28. Neurochem Int. 2014 Dec;78:76-85 - PubMed
  29. Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):1-10 - PubMed
  30. Phytother Res. 2006 Jun;20(6):427-37 - PubMed
  31. Alzheimer Dis Assoc Disord. 2016 Jul-Sep;30(3):223-9 - PubMed
  32. Chin Med. 2011 Apr 22;6:15 - PubMed
  33. J Mol Neurosci. 2015 Aug;56(4):977-87 - PubMed
  34. Int J Cardiol. 2013 Sep 30;168(2):1349-59 - PubMed
  35. Trials. 2016 Jun 08;17(1):281 - PubMed
  36. Acta Neuropathol. 2009 Jul;118(1):87-102 - PubMed
  37. Transl Neurodegener. 2013 Feb 28;2(1):6 - PubMed
  38. J Neurol Sci. 2009 Aug 15;283(1-2):224-9 - PubMed
  39. Hum Psychopharmacol. 2002 Aug;17 (6):267-77 - PubMed
  40. J Neuroimmune Pharmacol. 2014 Mar;9(2):245-58 - PubMed
  41. Phytother Res. 2001 Aug;15(5):449-51 - PubMed
  42. PLoS One. 2014 Feb 05;9(2):e88176 - PubMed
  43. Lancet Neurol. 2007 Jul;6(7):611-9 - PubMed
  44. Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1193-204 - PubMed
  45. J Ginseng Res. 2015 Oct;39(4):299-303 - PubMed
  46. Lancet. 2001 Jan 20;357(9251):169-75 - PubMed
  47. BMC Complement Altern Med. 2016 Jan 13;16:15 - PubMed
  48. Di Yi Jun Yi Da Xue Xue Bao. 2003 Sep;23(9):969-71 - PubMed
  49. JAMA. 2004 Dec 15;292(23):2901-8 - PubMed
  50. Stroke. 2011 Sep;42(9):2672-713 - PubMed
  51. Neurosci Res. 1997 Jul;28(3):191-200 - PubMed
  52. Lancet Neurol. 2005 Nov;4(11):752-9 - PubMed
  53. Eur J Neurol. 2008 Aug;15(8):865-8 - PubMed
  54. Bioorg Med Chem. 2008 Oct 1;16(19):8868-74 - PubMed
  55. Curr Neuropharmacol. 2013 Jul;11(4):430-5 - PubMed
  56. Neurol Res. 2007 Apr;29(3):270-3 - PubMed
  57. J Neurol Neurosurg Psychiatry. 2005 Dec;76 Suppl 5:v35-44 - PubMed
  58. Eur Heart J. 2014 Apr;35(14):888-94 - PubMed
  59. Neurosci Lett. 2010 Dec 17;486(3):246-51 - PubMed
  60. Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):18-25 - PubMed
  61. Phytomedicine. 2015 Feb 15;22(2):283-9 - PubMed
  62. Cell Biochem Biophys. 2012 Jan;62(1):55-8 - PubMed
  63. Br J Rheumatol. 1993 Apr;32(4):291-6 - PubMed
  64. Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S89-94 - PubMed
  65. Aging Clin Exp Res. 2012 Apr;24(2):113-6 - PubMed
  66. Cell Mol Neurobiol. 2016 Mar;36(2):281-8 - PubMed
  67. Biol Pharm Bull. 2014;37(2):274-85 - PubMed
  68. Behav Brain Res. 2013 Sep 15;253:212-6 - PubMed
  69. Chem Biodivers. 2011 Jul;8(7):1189-204 - PubMed
  70. Behav Brain Res. 2009 Aug 12;201(2):311-7 - PubMed
  71. Anat Cell Biol. 2012 Jun;45(2):92-6 - PubMed
  72. J Neurosci Res. 2012 Aug;90(8):1662-9 - PubMed
  73. Nat Rev Neurosci. 2011 Mar;12(3):169-82 - PubMed
  74. Int J Neurosci. 2015;125(11):823-30 - PubMed
  75. Epidemiology. 2011 Sep;22(5):646-59 - PubMed
  76. J Res Med Sci. 2013 Aug;18(8):704-6 - PubMed
  77. Lancet. 2013 Jun 8;381(9882):2016-23 - PubMed
  78. Planta Med. 2001 Oct;67(7):634-7 - PubMed
  79. Nat Rev Neurosci. 2011 Nov 03;12(12):723-38 - PubMed
  80. Zhongguo Zhong Yao Za Zhi. 2010 Jul;35(14):1883-6 - PubMed
  81. Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):222-6 - PubMed
  82. Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1598-614 - PubMed
  83. J Rheumatol. 2010 Oct;37(10):2032-8 - PubMed
  84. Eur J Pharmacol. 2003 Apr 25;467(1-3):41-7 - PubMed
  85. Neurol Clin. 2007 Aug;25(3):717-40, vi - PubMed
  86. J Neuroimmunol. 2012 Apr;245(1-2):79-86 - PubMed
  87. BMJ Open. 2016 Mar 25;6(3):e010295 - PubMed
  88. Neurosci Lett. 2004 Nov 30;372(1-2):40-5 - PubMed
  89. Anat Sci Int. 2013 Sep;88(4):217-22 - PubMed
  90. Pharmacol Biochem Behav. 2003 Jun;75(3):675-86 - PubMed
  91. J Int Neuropsychol Soc. 2009 Nov;15(6):915-23 - PubMed
  92. Ann Transl Med. 2014 Aug;2(8):80 - PubMed
  93. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007365 - PubMed
  94. Front Cell Neurosci. 2015 Jan 20;8:457 - PubMed
  95. Sci Rep. 2015 Jun 03;5:10353 - PubMed
  96. Behav Brain Res. 2016 Oct 15;313:144-50 - PubMed
  97. Neural Regen Res. 2013 Jun 25;8(18):1685-92 - PubMed
  98. J Ethnopharmacol. 2008 Feb 12;115(3):441-8 - PubMed
  99. Acta Pharmacol Sin. 2007 Mar;28(3):327-33 - PubMed

Publication Types